![Peter Schøtt Knudsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Schøtt Knudsen
Nessuna posizione attualmente
Profilo
Peter Schøtt Knudsen worked as the Head of Investor Relations at Veloxis Pharmaceuticals A from 2007 to 2010.
Precedenti posizioni note di Peter Schøtt Knudsen
Società | Posizione | Fine |
---|---|---|
VELOXIS PHARMACEUTICALS A/S | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Veloxis Pharmaceuticals A/S
![]() Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Peter Schøtt Knudsen